 BRIDGEWATER, N.J., May 11, 2021 PRNewswire -- Insmed Incorporated Nasdaq: INSM announced today that it priced a registered underwritten public offering of 10,000,000 shares of its common stock the Shares at a price to the public of 25.00 per share before deducting underwriting discounts and commissions, and a registered underwritten public offering of 500 million aggregate principal amount of its 0.75 convertible senior notes due 2028 the Notes. 